Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)
China · Delayed Price · Currency is CNY 21.95
+0.12 (0.55%)
Sep 29, 2025, 2:45 PM CST
SHA:605033 Revenue
Shaanxi Meibang Pharmaceutical Group had revenue of 195.92M CNY in the quarter ending June 30, 2025, a decrease of -0.81%. This brings the company's revenue in the last twelve months to 861.25M, up 17.58% year-over-year. In the year 2024, Shaanxi Meibang Pharmaceutical Group had annual revenue of 885.53M with 26.68% growth.
Revenue (ttm)
861.25M
Revenue Growth
+17.58%
P/S Ratio
3.45
Revenue / Employee
862.98K
Employees
998
Market Cap
2.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 885.53M | 186.50M | 26.68% |
| Dec 31, 2023 | 699.03M | -207.02M | -22.85% |
| Dec 31, 2022 | 906.05M | 63.56M | 7.54% |
| Dec 31, 2021 | 842.49M | 273.97M | 48.19% |
| Dec 31, 2020 | 568.52M | 52.81M | 10.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wanhua Chemical Group | 175.90B |
| Shandong Gold Mining | 93.51B |
| China Northern Rare Earth (Group) High-Tech Co.,Ltd | 38.84B |
| Baoshan Iron & Steel | 310.24B |
| Ningxia Baofeng Energy Group | 38.91B |
| Hengli Petrochemical | 227.72B |
| Zhejiang Huayou Cobalt | 68.09B |
| Qinghai Salt Lake Industry Co.,Ltd | 14.68B |